WJPR Citation New

  All Since 2019
 Citation  7475  4312
 h-index  28  21
 i10-index  197  83

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

PROTEIN KINASE: STRUCTURE, FUNCTION, AND ITS ACTION ON VARIOUS DISEASES.

Greeshma Sebastian, Jaishna Jayachandran Nambiar, Jazeela Abdulkhader, Ayisha Ummer, Shifla Kareem, Minil Mukundan, Aiswarya Lakshmi Appil Gopalakrishnan and Siju Ellickal Narayanan*

.

Abstract

Protein kinase is a very important drug target that helps in the regulation of cells. Protein kinase C-related kinases are of three types of PRK, PRK 1, PRK 2, and PRK 3, PRK 3 was first detected in metastatic cancers and later was found in low levels in all tissues. The specificity of phosphorylation by protein kinase is important for the integrity of signal transduction. Protein kinase is responsible for communication that occurs between one cell or a part of the cell to another called signal transduction. Different kinase inhibitors include Type I, II, III, and IV. AMP-activated protein kinase combines various regulatory signals. Receptor tyrosine kinases regulate the information transferred through signal transduction pathways. Tyrosine kinases have become important targets for drug discovery due to their involvement in the development and progression of tumors. Protein kinases have a role in several biological processes, including differentiation, cell survival, and cell cycle regulation. The largest protein family the human genome's gene coding represents is the G protein-coupled receptor (GPCR) family. Nuclear receptors (NR) are those that are located inside the nucleus and the molecules should enter into the cell to bind to the receptor. The activation of central MAPKs by kinase cascades activates transcription factors that cause inflammation in Asthma. The suppression of DNA-protein kinase can increase cellular sensitivity to IR and DNAdamaging substances in cancer therapy. The specific CK2 inhibitor CX-4945 has repeatedly been demonstrated to limit the DNA repair response to anticancer medications.

Keywords: Protein kinase, Signalling, Receptor, Tyrosine Kinase, Inhibitors.


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More